Gilead Sciences (GILD) Free Cash Flow (2009 - 2026)
Gilead Sciences (GILD) reported Free Cash Flow of $3.43 billion for Q2 2026, up 376.8% from $720 million a year earlier and up 41.5% from the prior quarter.
Gilead Sciences (GILD) Free Cash Flow (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Gilead Sciences' Free Cash Flow came in at $12.94 billion, up 38.1% year-over-year; for FY2025, it was $9.46 billion, down 8.2% from FY2024.
- Free Cash Flow has a five-year compound annual growth rate of 4.7% (FY2020 to FY2025).
- By year, Free Cash Flow came in at $10.31 billion in FY2024 (+38.9%), $7.42 billion in FY2023 (-11.1%), $8.34 billion in FY2022 (-22.8%) and $10.81 billion in FY2021 (+43.7%).
- Five-year quarterly Free Cash Flow spans a low of $720 million in Q2 2025 and a high of $4.17 billion in Q3 2024.
- Year over year, Free Cash Flow has now increased in each of the last three quarters, with growth averaging 70.9% over the last eight quarters.
- The high point for year-over-year Free Cash Flow in five years was Q2 2026 (growth of 376.8%); the low point was Q2 2024 (a decline of 45.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $2.43 billion (Q1 2026), $3.12 billion (Q4 2025) and $3.96 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.76 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 7.30 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.11 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.48 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 6.20 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 5.34 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 3.49 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.43 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 302.00 Mn |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | 1.01 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.43 Bn |
| Mar 31, 2026 | 2.43 Bn |
| Dec 31, 2025 | 3.12 Bn |
| Sep 30, 2025 | 3.96 Bn |
| Jun 30, 2025 | 720.00 Mn |
| Mar 31, 2025 | 1.65 Bn |
| Dec 31, 2024 | 2.83 Bn |
| Sep 30, 2024 | 4.17 Bn |
| Jun 30, 2024 | 1.20 Bn |
| Mar 31, 2024 | 2.11 Bn |
| Dec 31, 2023 | 1.95 Bn |
| Sep 30, 2023 | 1.63 Bn |
| Jun 30, 2023 | 2.20 Bn |
| Mar 31, 2023 | 1.64 Bn |
| Dec 31, 2022 | 2.39 Bn |
| Sep 30, 2022 | 2.71 Bn |
| Jun 30, 2022 | 1.66 Bn |
| Mar 31, 2022 | 1.59 Bn |
| Dec 31, 2021 | 3.05 Bn |
| Sep 30, 2021 | 3.11 Bn |
Gilead Sciences Free Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=free-cash-flow&ticker=GILD&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "free-cash-flow", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=free-cash-flow&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();